Literature DB >> 920242

Studies on replacement and suppressive dosages of 1-thyroxine.

G Nilsson, U Pettersson, K Levin, R Hughes.   

Abstract

Serum thyrotropin (TSH) levels were studied in 55 hypothyroid patients in order to determine adequate replacement and suppression dosages of 1-thyroxine (T4). In accordance with previous reports it was found that most patients had normal TSH levels and were clinically euthyroid at daily doses of 0.10-0.15 mg T4. None of the patients required a dose exceeding 0.20 mg. When the TSH levels normalized, serum thyroxine and serum triiodothyronine also fell to levels within their normal ranges. The effectiveness of various doses of T4 in suppressing the temporary rise in serum TSH concentration normally induced by thyrotropin-releasing hormone was examined in 57 patients treated with T4 for atoxic goitre or after subtotal surgical removal of such a goitre. The rise in TSH was not usually inhibited by a T4 dose of less than 0.20 mg, a finding which at least theoretically has implications for the adequate suppressive dose of T4.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 920242     DOI: 10.1111/j.0954-6820.1977.tb16823.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

1.  Hyperthyrotrophinaemia during thyroxine replacement therapy.

Authors:  P McClelland; A Stott; W Howel-Evans
Journal:  Postgrad Med J       Date:  1989-04       Impact factor: 2.401

2.  Familial inappropriate TSH secretion: evidence suggesting a dissociated pituitary resistance to T3 and T4.

Authors:  J L Vandalem; G Pirens; G Hennen
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

3.  Maintenance requirements of L-thyroxine in the treatment of hypothyroidism.

Authors:  W A Kehoe; B J Dong; F S Greenspan
Journal:  West J Med       Date:  1984-06

4.  Thyroxine replacement therapy: prescribing patterns and problems in 2710 patients. Scottish Automated Follow-up Register Group.

Authors: 
Journal:  Br Med J       Date:  1980-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.